Evidence map›Paper›PMID 40713498›Full record

ArticleBMC infectious diseases2025

Trends and patterns of antimicrobial resistance among common pathogens isolated from adult bloodstream and urinary tract infections in public health facilities in Malawi, 2020-2024.

Akim N Bwanali, Adriano Focus Lubanga, Sibongile Kondowe, Ellen Nzima, Anne Mwale, Watipaso Kamanga, Chrispin Enerico, Cresencia Masautso, Thandizo Kapatsa, Steward Mudenda and 7 more

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Akim N BwanaliClinical Research Education and Management Services (CREAMS), P. O Box 31045, Anderson House, Area 43, Lilongwe, Malawi.
Adriano Focus LubangaClinical Research Education and Management Services (CREAMS), P. O Box 31045, Anderson House, Area 43, Lilongwe, Malawi. lubangafocusadriano1@gmail.com.
Sibongile KondoweMinistry of Health, Antimicrobial Resistance National Coordination Centre, Public Health Institute of Malawi, Lilongwe, Malawi.
Ellen NzimaMinistry of Health, Antimicrobial Resistance National Coordination Centre, Public Health Institute of Malawi, Lilongwe, Malawi.
Anne MwaleMinistry of Health, Antimicrobial Resistance National Coordination Centre, Public Health Institute of Malawi, Lilongwe, Malawi.
Watipaso KamangaClinical Research Education and Management Services (CREAMS), P. O Box 31045, Anderson House, Area 43, Lilongwe, Malawi.
Chrispin EnericoClinical Research Education and Management Services (CREAMS), P. O Box 31045, Anderson House, Area 43, Lilongwe, Malawi.
Cresencia MasautsoAntimicrobial Resistance Coordinating Committee, National Public Health Institute, Lusaka, Zambia.
Thandizo KapatsaDepartment of Microbiology, Dedza District Hospital, Dedza, Malawi.
Steward MudendaDepartment of Pharmacy, School of Health Sciences, University of Zambia, Lusaka, Zambia.
Samuel MpinganjiraDepartment of Global Health, University of Washington, Seattle Campus, Seattle, WA, USA.
Gillian MwaleDepartment of Obstetrics and Gynecology, Queen Elizabeth Central Hospital, Blantyre, Malawi.
Cynthia ChituleClinical Research Education and Management Services (CREAMS), P. O Box 31045, Anderson House, Area 43, Lilongwe, Malawi.
Alinafe KaweramaMinistry of Health, Antimicrobial Resistance National Coordination Centre, Public Health Institute of Malawi, Lilongwe, Malawi.
Innocent ChibweMinistry of Health, Antimicrobial Resistance National Coordination Centre, Public Health Institute of Malawi, Lilongwe, Malawi.
Thomas NyirendaClinical Research Education and Management Services (CREAMS), P. O Box 31045, Anderson House, Area 43, Lilongwe, Malawi.
Collins MitamboMinistry of Health, Antimicrobial Resistance National Coordination Centre, Public Health Institute of Malawi, Lilongwe, Malawi.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionBacterial bloodstream and urinary tract infections present a huge health burden especially in low-resource settings, which is worsened by the escalating burden of antimicrobial resistance (AMR). However, surveillance data on antimicrobial susceptibility profiles of pathogens remains scarce in Malawi. Therefore, this study aimed at establishing trends and patterns of AMR among common pathogens causing adult bloodstream and urinary tract infections in Malawi.

methodsThis was a secondary analysis of records from bacterial culture and susceptibility testing results of routinely collected adult blood and urinary tract samples from seven facilities in Malawi between January 2020 and August 2024. Antimicrobial susceptibility testing (AST) was performed using the disk diffusion method and interpreted according to EUCAST guidelines. The outcome of interest was the AST results of the bacterial isolates. Data were analyzed using SPSS version 28.

resultsOut of the 2787 isolates collected, 80.6% (n = 2246) were from urine samples and 19.4% (n = 541) were from blood samples. 74.1% (n = 2066) of the isolates were Gram-negative organisms. Escherichia coli (37.6%, n = 1048) and Klebsiella pneumoniae (8.3%, n = 232) were the most frequent isolates. A total of 16,696 ASTs were performed on the isolates, with 54.3% (n = 9,068) showing resistance to the antibiotics tested. Among Gram-positive organisms, there was increasing resistance to co-trimoxazole (71.4-83.3%), vancomycin (20.0-31.0%), with consistently high resistance rates to ciprofloxacin, erythromycin and gentamicin. Gram-negative organisms showed trends of increasing resistance to ceftriaxone (63.0-72.4%), co-trimoxazole (72.7-89.7%), and piperacillin and tazobactam (0.0-35.8%), with a notable significant increase in resistance to ciprofloxacin (66.7-81.0%, p = 0.001). There was an increasing trend of Enterobacteriaceae resistance to third-generation cephalosporins (58.9-71.5%). Overall, pathogens with the highest resistance include Citrobacter freundii (62.1%, n = 755/1216), Staphylococcus sp. (62.0%, n = 163/263) and K. pneumoniae (57.1%, n = 941/1648). Among the commonly isolated pathogens, E. coli, K. pneumoniae and Enterobacter spp. showed highest resistance to multiple antibiotics.

conclusionThe study revealed high resistance levels among pathogens that cause BSIs and UTIs in public hospitals in Malawi. Most pathogens demonstrated high resistance against multiple antibiotic classes. The high AMR trends and patterns pose a significant risk to healthcare provision, calling for enhancing surveillance and upscaling efforts to address the challenge.

Indexed as

Anti-Bacterial AgentsBacteremiaBacteriaDrug Resistance, BacterialUrinary Tract InfectionsAdultDrug Resistance, Multiple, BacterialFemaleHealth FacilitiesHumansMalawiMaleMicrobial Sensitivity TestsMiddle AgedAnti-Bacterial AgentsAMR trendsAntibiotic susceptibilityAntimicrobial resistanceBacterial isolatesBloodstream infectionsResistance patternsSurveillanceUrinary tract infections

Identifiers

PMID40713498
PMCPMC12297731

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.